Current chemotherapy of schistosomiasis japonica in the Philippines.
Southeast Asian J Trop Med Public Health
;
1976 Jun; 7(2): 306-9
Article
Dans Anglais
| IMSEAR
| ID: sea-34655
ABSTRACT
For the past several decades, the drug being used for the treatment of schistosomiasis in the Philippines has been Stibophen. It is administered intramuscularly at a dose of 1 ml per 10 kg body weight with a maximum of 5 ml every other day after 2 initial daily smaller sensitivity doses at a total dose of 45 to 70 ml fof adult patients. In recent years, a number of drugs for the treatment of schistosomiasis have been developed. These were evaluated clinically either in the hospital or in field trials in Leyte. Unfortunately, none of these were found to be suitable for mass treatment on account of toxicity to prolonged course of treatment. In view of the pressing need for a safe and effective schistosomicidal agent, the search for a better drug is imperative.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Schistosomiase
/
Schistosomicides
/
Tartrates
/
Benzènesulfonates
/
Humains
/
Essais cliniques comme sujet
/
Adulte
/
Cystéine
/
Évaluation de médicament
/
Dérivés de l'aniline
langue:
Anglais
Texte intégral:
Southeast Asian J Trop Med Public Health
Année:
1976
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS